C57BL/6NCrl-Nr2f1em1Ics/Ics

Status

Available to order

EMMA IDEM:16193
Citation informationRRID:IMSR_EM:16193 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6NCrl-Nr2f1em1Ics/Ics
Alternative nameNr2f1em1Ics/Ics
Strain typeEndonuclease-mediated
Allele/Transgene symbolNr2f1em1Ics
Gene/Transgene symbolNr2f1

Information from provider

ProviderMichele Studer
Provider affiliationPhysiological and Pathological Mechanisms of Neural Development Lab, Institute of Biology Valrose, i, CNRS 7277- Inserm 1091-Univ. Côte d’Azur (UniCA) Centre de Biochimie
Genetic informationCRISPR/Cas9 technology generated a glutamic acid 397 (GAA) to TGA stop codon change (c.1189-1190delGAinsTG, p.E397*) in exon 3. A silent mutation also introduced an NdeI restriction site. A single guided RNA TCTCGGATGAGAGTTTCGAT was selected for the position of the putative double stand break being close to the mutation to introduce. A single stranded phosphorothioate oligonucleotide (donor ssODN) was used, with the following sequence: TGTCCTCCTCTGTCATCGAGCAACTCTTCTTCGTACGTTTGGTAGGTAAAACTCCCATATGAACTCTCATCCGAGATATGTTGCTGTCAGGGAGCAGTTTCAACTGGCCTTACATGTCCA .
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding historyC57BL/6NCrl 100%
References
  • Models of Bosch-Boonstra-Schaaf optic atrophy syndrome reveal genotype-phenotype correlations in brain structure and behavior.;Maass Johann G, Kamionek Dominik, Mantilleri Annabelle, Theiss Susanne, Dötsch Laura, Franke Felix, Schubert Tim, Scheck Jonas G, Pitzer Claudia, Piovani Paolo, Bertacchi Michele, Deschaux Olivier, Singh Anubhav, Chen Chun-An, Fröhlich Henning, Studer Michèle, Schaaf Christian P, ;2025;Disease models & mechanisms;18;; 40855817
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • embryonic growth retardation / IMPC
  • persistence of hyaloid vascular system / IMPC
  • abnormal auditory brainstem response / IMPC
MGI phenotypes (gene matching)
  • abnormal corpus callosum morphology / MGI
  • abnormal cerebral cortex morphology / MGI
  • absent barrels in primary somatosensory cortex / MGI
  • abnormal glossopharyngeal ganglion morphology / MGI
  • no swallowing reflex / MGI
  • abnormal hearing physiology / MGI
  • no abnormal phenotype detected / MGI
  • abnormal brain commissure morphology / MGI
  • abnormal neuron morphology / MGI
  • abnormal axon guidance / MGI
  • no phenotypic analysis / MGI
  • abnormal cochlear sensory epithelium morphology / MGI
  • nervous system phenotype / MGI
  • abnormal cingulate gyrus morphology / MGI
  • increased cochlear inner hair cell number / MGI
  • increased cochlear outer hair cell number / MGI
  • increased cochlear hair cell number / MGI
  • abnormal orientation of outer hair cell stereociliary bundles / MGI
  • abnormal orientation of inner hair cell stereociliary bundles / MGI
  • abnormal cochlear hair cell development / MGI
  • increased Deiters cell number / MGI
  • abnormal axon morphology / MGI
  • abnormal hippocampal commissure morphology / MGI
  • abnormal anterior commissure morphology / MGI
  • abnormal organ of Corti supporting cell differentiation / MGI
  • short scala media / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI

Literature references

  • Models of Bosch-Boonstra-Schaaf optic atrophy syndrome reveal genotype-phenotype correlations in brain structure and behavior.;Maass Johann G, Kamionek Dominik, Mantilleri Annabelle, Theiss Susanne, Dötsch Laura, Franke Felix, Schubert Tim, Scheck Jonas G, Pitzer Claudia, Piovani Paolo, Bertacchi Michele, Deschaux Olivier, Singh Anubhav, Chen Chun-An, Fröhlich Henning, Studer Michèle, Schaaf Christian P, ;2025;Disease models & mechanisms;18;; 40855817

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).